# A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems

> **NCT02738840** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 56 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **PROCEDURE:** MRI scan

## Key facts

- **NCT ID:** NCT02738840
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-21
- **Primary completion:** 2020-12
- **Final completion:** 2020-12-02
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02738840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02738840, "A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02738840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*